| DC23899 |
Bromocriptine mesylate
Featured
|
Bromocriptine (CB-154) is a dopamine D2 receptor agonist (Ki=3 nM) and and various serotonin receptors, also inhibits the release of glutamate by reversing the glutamate GLT1 transporter. |
|
| DC8386 |
Bromodeoxyuridine (BrdU)
Featured
|
Bromodeoxyuridine (BrdU) is a nucleoside analog that competes with thymidine for incorporation into DNA, and used in the detection of proliferating cells. |
|
| DC7543 |
Bromosporine
Featured
|
Bromosporine is a broad spectrum bromodomain inhibitor. Accelerates FRAP recovery of BRD4 and CREBBP in cells at a concentration of 1 μM. |
|
| DC12633 |
Bromotriazine |
Bromotriazine (BTZ) is a covalent probe against bromodomain containing proteins with selectively targeting non-catalytic, highly conserved amino acid residues.. |
|
| DC23385 |
BRPF1B TRIM24-IN-34 |
BRPF1B TRIM24-IN-34 is a selective BRPF1B/TRIM24 dual inhibitor that binds with KD of 137 and 222 nM, respectively. |
|
| DC10460 |
BT-11
Featured
|
BT-11 is an orally active and selective LANCL2 modulator. |
|
| DC10164 |
BTB-1
Featured
|
BTB-1 is a small molecule inhibitor of the mitotic motor protein Kif18A. |
|
| DC20199 |
BTK inhibitor 1;Compound 27
Featured
|
BTK inhibitor 1 (Compound 27) |
|
| DC26026 |
Btk inhibitor 2 |
Btk inhibitor 2 is a Bruton's tyrosine kinase (BTK) inhibitor extracted from patent US 20170224688 A1. |
|
| DC12432 |
BTK inhibitor 4b |
BTK inhibitor 4b is a potent, highly selective inhibitors of BTK with IC50 of 4.2 and 0.9 nM against activated and unactivated BTK, respectively. |
|
| DC11431 |
BTK-030 |
BTK-030 is a novel BTK inhibitor. |
|
| DC23870 |
BTK-IN-23 |
BTK-IN-23 is a highly potent and selective Btk inhibitor with IC50 of 3 nM. |
|
| DC23413 |
BTRX335140
Featured
|
BTRX-335140 (CYM-53093, BTRX335140, CYM53093) is a potent, selective, orally active κ opioid receptor (KOR) antagonist with IC50 of 0.8 nM. |
|
| DC12456 |
BTT-266
Featured
|
BTT-266 (BTT266) is a voltage-gated CaV2.2 calcium channel inhibitor that disrupts the CaVα·CaVβ3 protein-protein interaction, directly binds to CaVβ3 with Kd of 3.6 uM. |
|
| DC12457 |
BTT-369 |
BTT-369 (BTT369) is a voltage-gated CaV2.2 calcium channel inhibitor that disrupts the CaVα·CaVβ3 protein-protein interaction with Ki of 2.0 uM in FP assays. |
|
| DC23703 |
BTYNB
Featured
|
BTYNB is a potent and selective inhibitor of IMP1 binding to c-Myc mRNA with IC50 of 5 uM. |
|
| DC22041 |
BTZO-1
Featured
|
BTZO-1 is a cardioprotective agent and Macrophage migration inhibitory factor (MIF) activator, binds to MIF with Kd of 68.6 nM, regulates ARE-mediated gene expression. |
|
| DC22042 |
BTZO-15 |
BTZO-15 is an active BTZO-1 derivative for ARE-activation with a favorable ADME-Tox profile, induces expression of heme oxygenase-1 (HO-1) and inhibits NO-induced cell death in IEC-18 cells. |
|
| DC22043 |
BTZO-2 |
BTZO-2 is an active BTZO-1 derivative, an antioxidant response element-activator, provides protection against lethal endotoxic shock in mice.. |
|
| DCAPI1209 |
Budesonide |
Budesonide |
|
| DC6501 |
Bufalin
Featured
|
Bufalin inhibits steroid receptor coactivator 1 (SRC-1) and SRC-3 at doses as low as 5 nM, promotes the degradation of SRC-3 protein, and inhibits cancer cell growth both in vitro and in vivo. |
|
| DCAPI1160 |
Buflomedil HCl |
Buflomedil HCl |
|
| DCAPI1459 |
Bupivacaine HCL |
Bupivacaine HCL |
|
| DC22437 |
Burimamide oxalate |
Burimamide oxalate is a potent dual H3/H2 receptor antagonist with Ki of 0.07 and 7.8 uM, respectively. |
|
| DC20059 |
Burixafor hydrobromide (TG-0054 hydrobromide) |
Burixafor hydrobromide (TG-0054 hydrobromide) is an orally bioavailable and potent antagonist of CXCR4 and a well water soluble anti-angiogenic drug that is of potential value in treating choroid neovascularization. Burixafor hydrobromide (TG-0054 hydrobr |
|
| DC8995 |
Busulfan/Myleran |
Busulfan is a bifunctional alkylating agent. |
|
| DCAPI1407 |
Butenafine |
Butenafine |
|
| DC21685 |
BVT-948
Featured
|
BVT-948 (SPS8I-3) is a noncompetitive, cell-permeable inhibitor of protein tyrosine phosphatases (PTPs) with IC50 of 0.09-1.7 uM. Results show that the effect of BVT948 (BVT.948) is to strengthen the insulin signal and has no effects on the duration of th |
|
| DC20852 |
BX-320 |
BX-320 is a potent, selective and ATP-competitive inhibitor of PDK1 with IC50 of 30 nM, >20-fold selectivity over PKA. |
|
| DC8808 |
BX-513 hydrochloride
Featured
|
BX-513 hydrochloride inhibits MIP-1α-induced intracellular calcium mobilization (IC50 = 2.5 μM). |
|
